How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.

Leucht, S, Arbter, D, Engel, R R, Kissling, W, Davis, J M·2009·Molecular Psychiatry
DOI 10.1038/sj.mp.4002136

Cited by (489)

Items 401–489 of 489

  1. Psychiatry: The State of the Art
    Konstantinos Ν. Fountoulakis · 2021 · Springer eBooks
  2. A new approach for evolution and quantification of Triamcinolone acetonide in medication shots by using RP-HPLC
    Manikantha Naveen Vuddagiri, Boddu Veeraswami · 2021 · Journal of Applied Pharmaceutical Science
  3. Panel Session
    2010 · Neuropsychopharmacology
  4. Services for people with severe mental disorders in high‐income countries
    Paul Bebbington, Elizabeth Kuipers, David G. Fowler · 2013 · Wiley eBooks
  5. Are we reinforcing the anti-medical model?
    Dorothea Bindman, Mukesh Kripalani · 2014 · The British Journal of Psychiatry
  6. Electronic monitoring of forensic patients
    Alexander I. F. Simpson, Stephanie R. Penney · 2014 · The British Journal of Psychiatry
  7. Commentary: The current state of psychopharmacology and psychiatry
    Ross J. Baldessarini · 2011 · Revista de Psiquiatría y Salud Mental (English Edition)
  8. Psychosis
    Tania M. Lincoln, Aaron Tim Beck · 2013 · Wiley eBooks
  9. Social motives as a psychological factor influencing negative symptoms in patients with schizophrenia
    Rahel Horisberger, Stefan Kaiser, Matthias N. Hartmann-Riemer · 2023
  10. Reply to a Letter to the Editors From Dr de Souza and colleagues: “Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum: A Quest for Clarity”
    Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Liss Gøril Anda, Else‐Marie Løberg, Solveig Klæbo Reitan, Inge Joa, Tor Ketil Larsen et al. · 2023 · Journal of Clinical Psychopharmacology
  11. Depression : can we predict who will relapse?
    Joshua E. J. Buckman · 2014 · UCL Discovery (University College London)
  12. Biological mechanisms behind clozapine- induced agranulocytosis
    Liisa Lahdelma · 2009 · Työväentutkimus Vuosikirja
  13. Evidenzbasierung und leitliniengestützte Therapie in der Psychiatrie
    Hans‐Jürgen Möller · 2011 · Springer eBooks
  14. Comparing tolerability profile of second generation antipsychotics in schizophrenia and affective disorders : a meta-analysis
    Hoda Moteshafi · 2011
  15. Cognitive Impairment in Schizophrenia : Related Risk Factors and Clinical Characteristics
    Minna Torniainen · 2013
  16. 5 – Pharmacologie de la schizophrénie
    Baptiste Pignon, Sarah Tebeka, Franck Schürhoff, Andreı̈ Szöke · 2015
  17. Some novelties and recommendations by swithing antipsychotics
    Nika Aleksandra Kravos, Matej Kravoš · 2014 · DOAJ (DOAJ: Directory of Open Access Journals)
  18. Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia
    Matthias J. Müller · 2011 · Schizophrenia Research and Treatment
  19. Challenging conventional models of psychiatric drug therapy: an alternative patient-centered approach
    Joanna Moncrieff · 2009 · Future Neurology
  20. A prospective study of cognitive deficits in first episode psychosis, and the response thereof to treatment with Flupenthixol Decanoate
    Renata Schoeman · 2011 · SUNScholar (Stellenbosch University)
  21. Genetic determinants of antipsychotic drug response
    Jochem G. Gregoor · 2012 · Utrecht University Repository (Utrecht University)
  22. Adherence to Treatment in Patients with Psychosis
    Anton B. P. Staring · 2010 · RePub (Erasmus University Rotterdam)
  23. research Clinical predictors of therapeutic response to antipsychotics in schizophrenia
    Maren Carbon, Christoph Ulrich Correll · 2014
  24. medication into perspective: review of meta-analyses Putting the efficacy of psychiatric and general medicine
    Stefan Leucht, Sandra Hierl, Werner Kissling, Markus Dold, John M. Davis · 2012
  25. Frontale Hirnvolumen- minderung durch Antipsychotika?
    Ernst-Moritz-Arndt-Universität Greifswald · 2015
  26. The Challenge of Adherence in Schizophrenia
    Fernando Cañas de Paz, José Manuel Olivares · 2013 · Evolving Medicine Ltd eBooks
  27. Quality of Life Assessments in the Development and Clinical Trials of New Antipsychotics: Pharmaceutical Industry Perspective
    R. Buller, Christophe Sapin · 2016 · Springer eBooks
  28. Metakognitives Training bei Schizophrenie
    Martina Fieker, Brooke C. Schneider · 2015 · Psychotherapeut
  29. Schizofrenie en suïcidaal gedrag
    Jef Hulselmans, D Lecompte, E De Bleeker, Marc D. Binder, F Janssen, Frederik Vandendriessche, C. Mertens, J. Peuskens, H Hellebuyck, Martien Wampers · 2009 · Lirias
  30. Glucagon-like Peptide 1 Receptor (GLP1R) Genetic Variants Impact Response to Olanzapine and Risperidone in Multiple Cohorts Across Two Independent Studies
    Timothy L. Ramsey, Mark D. Brennan · 2016 · Dual Diagnosis Open Access
  31. Untersuchungen zu den Beziehungen von Kognition und klinischer Symptomatik zu sozialem Funktionsniveau innerhalb einer großen Schizophrenie-Stichprobe
    Leppert, Richard · 2011 · eDiss (Georg-August-Universität Göttingen)
  32. Unmet medical needs in schizophrenia treatments
    Mujeeb Uddin Shad · 2012
  33. Assoziation von Höhe der antipsychotischen Medikation über die Zeit mit Kognition unter Berücksichtigung des Geschlechts
    Christoph Johannes Szuszies · 2012
  34. D2-Rezeptor-Agonist mit Schwerpunkt Negativsymptomatik
    Hans-Peter Volz · 2018 · DNP - Der Neurologe und Psychiater
  35. Molecular and Synaptic Alterations in the Striatum of GluN1-Deficient Mice
    Yuxiao Chen · 2018 · TSpace (University of Toronto)
  36. Stimmenhören und Recovery: erfahrungsfokussierte Beratung mit Stimmenhörenden – ein Aufruf zu neuen und mutigen Beziehungen
    Joachim Schnackenberg, Barbara Schumacher, Senait Debesay · 2019 · PPH
  37. Decision-Making in Deprescribing
    Swapnil Gupta, Rebecca A. Miller, John Daniel Cahill · 2019
  38. Behandlung unter besonderen Bedingungen (Modul 4c)
    Wolfgang Gäebel, Alkomiet Hasan, Peter Falkai · 2019 · Springer eBooks
  39. Pharmakotherapie und andere somatische Behandlungsverfahren (Modul 4a)
    Wolfgang Gäebel, Alkomiet Hasan, Peter Falkai · 2019 · Springer eBooks
  40. Efeitos da adição do mononitrato de isossorbida, um doador de óxido nítrico, ao tratamento habitual de pacientes com o diagnóstico de esquizofrenia
    Tiago M. Guimarães · 2020
  41. Non-Inferiority Margin Setting from Indirect Comparison
    Enass M. Duro · 2019 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  42. Psychiatric Research Ethics
    Dominic A. Sisti, William Smith · 2021 · Oxford University Press eBooks
  43. Asociación de las alteraciones en la metacognición con la presentación de las ideas delirantes en diferentes trastornos psiquiátricos
    Ramírez Ortíz, Jairo Alejandro · 2020
  44. From the Second Half of the Twentieth Century to the Early Twenty-First: The Psychopharmacologic Era
    K. Fountoulakis · 2021 · Psychiatry
  45. Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkankungen, 9. Auflage
    2013 · Elsevier eBooks
  46. Schizophrenie
    Steffen Moritz, Eva Carolin Krieger, Francesca Bohn, Ruth Veckenstedt · 2017 · Springer eBooks
  47. Antipsychotic Agents
    Ross J. Baldessarini · 2012 · Springer eBooks
  48. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2017 · Springer eBooks
  49. Current awareness in human psychopharmacology
    2009 · Human Psychopharmacology Clinical and Experimental
  50. Psychopharmaka
    Martin J. Lohse, Bruno Müller-Oerlinghausen · 2014 · Springer eBooks
  51. Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 13. Auflage
    2017 · Elsevier eBooks
  52. Antipsychotic Drugs
    2019 · American Psychiatric Association Publishing eBooks
  53. Evidenzbasierung und leitliniengestützte Therapie in der Psychiatrie
    Stefan Leucht, Hans‐Jürgen Möller · 2017 · Springer eBooks
  54. Schizophrenia
    Harald W. Sontheimer · 2021 · Elsevier eBooks
  55. Literaturverzeichnis zu Voderholzer/Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 14. Auflage
    2019 · Elsevier eBooks
  56. Literaturverzeichnis zu Voderholzer, Hohagen (Hrsg.): Therapie psychischer Erkrankungen, 10. Auflage
    2014 · Elsevier eBooks
  57. Antipsychotic Drugs
    2019 · American Psychiatric Association Publishing eBooks
  58. MKT+: Ein innovativer Ansatz
    Steffen Moritz, Eva Carolin Krieger, Francesca Bohn, Ruth Veckenstedt · 2017 · Springer eBooks
  59. Evidenzbasierung und leitliniengeschützte Therapie in der Psychiatrie
    Stefan Leucht, Hans‐Jürgen Möller · 2016 · Springer eBooks
  60. Cost analysis of lurasidone for the treatment of schizophrenia in adolescents and adults within the United Kingdom
    Amy Dymond, Daniela Afonso, Will Green · 2022 · BMC Health Services Research
  61. Understanding Schizophrenia: Introductory Aspect of the Mental Disorder from Various Perspectives
    Indranath Chatterjee · 2023 · Springer eBooks
  62. Risk factors for non-therapeutic adhesion in patients with schizophrenia
    Irina Dutu, Valentin Petre Matei, Cătălina Tudose · 2019 · Romanian Journal of Psychiatry & Psychotherapy
  63. Explicit and implicit motives of psychosis patients with negative symptoms
    Rahel Horisberger, Stefan Kaiser, Birgit Kleim, Philipp Homan · 2023 · PsyArXiv (OSF Preprints)
  64. ANALYSIS OF THE ANTIDEPRESSANT POTENTIAL OF PHYSICAL EXERCISE PRACTICE, MEDIATED BY NEUROPLASTICITY, IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SYSTEMATIC REVIEW ARTICLE
    Leonardo Carrijo Naves, Luan Alves Marques de Melo, Lucas Damião Anjos, Luis Fernando Rodrigues Assunção · 2023 · International Journal of Health Science
  65. Psychotic Disorders
    Tania M. Lincoln · 2015 · Wiley eBooks
  66. Paradigm Shift to Promote a Revolution of Treatment of Schizophrenia to Achieve Recovery
    Walter Keim · 2023 · Medical Research Archives
  67. Psychopharmacological Treatment of Schizophrenia
    Nirmal Singh, Suhas Ganesh, Deepak Cyril D’Souza · 2024 · Elsevier eBooks
  68. Chapter 4. Antipsychotic Drugs
    2024 · American Psychiatric Association Publishing eBooks
  69. An intersectional perspective on the sociodemographic and clinical factors influencing the status of not in Education, Employment, or training (NEET) in patients with first-episode psychosis (FEP)
    Jiaxuan Deng, Lisa Sarraf, Adèle Hotte‐Meunier, Stéphanie El Asmar, Jai L. Shah, Ridha Joober, ASHOK K. MALLA, Srividya N. Iyer, Martín Lepage, Geneviève Sauvé · 2024 · Social Psychiatry and Psychiatric Epidemiology
  70. Literaturverzeichnis zu Voderholzer (Hrsg.): Therapie psychischer Erkrankungen, 20. Auflage
    2024 · Elsevier eBooks
  71. Current Treatments for Schizophrenia
    DONALD C. GOFF · 2025
  72. Antipsykotika har god effekt ved psykoselidelser
    Erik Johnsen, Ole A. Andreassen, Ingrid Melle, Jan Ivar Røssberg, Melissa Authen Weibell, Rune A. Kroken · 2025 · Tidsskrift for Den norske legeforening
  73. Delayed Negative Symptom Response To Antipsychotics: An Individual Participant Data Analysis
    Stefan Leucht, Mathias Harrer, Susan Illing, Stephen Z. Levine · 2025 · medRxiv
  74. Treatment discontinuation of remotely delivered cognitive remediation for schizophrenia: a systematic review and meta-analysis
    Min Wen, Jie Zhang, Keqing Jiang, Juan Liu, Xiaodan Zhu · 2025 · Frontiers in Psychiatry
  75. Additional file 3 of The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review
    Grünwald, L. M., Claire Duddy, Richard Byng, Nadia E. Crellin, Joanna Moncrieff · 2021 · Figshare
  76. Additional file 4 of The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review
    Grünwald, L. M., Claire Duddy, Richard Byng, Nadia E. Crellin, J. Moncrieff · 2021 · Figshare
  77. Additional file 2 of The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review
    Grünwald, L. M., Claire Duddy, Richard Byng, Nadia E. Crellin, Joanna Moncrieff · 2021 · Figshare
  78. Additional file 1 of The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review
    Grünwald, L. M., Claire Duddy, Richard Byng, Nadia E. Crellin, Joanna Moncrieff · 2021 · Figshare
  79. Additional file 1 of Cost analysis of lurasidone for the treatment of schizophrenia in adolescents and adults within the United Kingdom
    Amy Dymond, Daniela Afonso, Green, Will · 2022 · Figshare
  80. Impact of Clozapine on Neutrophil and White Blood Cell Counts
    SAMET ULUDAĞ, kadir uludag · 2026 · IGI Global eBooks
  81. Évaluation des neuroleptiques : impact populationnel et analyse des stratégies thérapeutiques
    G. Désaméricq · 2014 · theses.fr (ABES)
  82. Inflammation, infections et maladies mentales : identification de biomarqueurs et applications thérapeutiques potentielles
    Guillaume B. Fond · 2016 · theses.fr (ABES)
  83. Role of immune and nervous system interaction : pre-clinical and clinical studies
    Douglas Daoudlarian · 2018 · theses.fr (ABES)
  84. Fatigue and its associations in schizophrenia : Insights from negative symptoms, fatigue catastrophizing, and physical activity studies
    Yasmine Laraki · 2023 · theses.fr (ABES)
  85. Tetracycline antibiotics: Emerging roles in neuropsychiatric disorders
    Ayşe Şiva Acar, Öykü Saday, Oytun Erbaş · 2024 · Demiroglu Science University Florence Nightingale Journal of Medicine
  86. Medications for Psychosis in People with Schizophrenia
    Ambarin Faizi, Stephen M. Stahl · 2026 · Cambridge University Press eBooks
  87. Antipsychotic Drugs and the Risk of Diabetic Complications: A Systematic Review of Observational Studies
    Nisrine Haddad, Nawal Farhat, Christopher A. Gravel, Yue Chen, Franco Momoli, Donald R. Mattison, Jeannette Goguen, Daniel R. Krewski · 2026 · Journal of Clinical Medicine
  88. Digital Health Technologies for Psychotic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (Preprint)
    Roxana Mihaela Mărginean, Anca Dobrean, Denis Pavăl, Raluca Mardan, Sarah L. Kopelovich, Raluca Georgescu · 2026 · Journal of Medical Internet Research
  89. Is a higher antipsychotic dose required to treat relapse in remitted first episode psychosis? A systematic review and meta-analysis
    Victoria Teague, Stephen Guilfoyle, Pauline Pocha, Thipa Paneer Chelvam, John Lally, Brian N. O'Donoghue · 2026 · Schizophrenia Research